Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 119(40): e2206990119, 2022 10 04.
Article in English | MEDLINE | ID: mdl-36161913

ABSTRACT

Rapid detection of pathogenic bacteria within a few minutes is the key to control infectious disease. However, rapid detection of pathogenic bacteria in clinical samples is quite a challenging task due to the complex matrix, as well as the low abundance of bacteria in real samples. Herein, we employ a label-free single-particle imaging approach to address this challenge. By tracking the scattering intensity variation of single particles in free solution, the morphological heterogeneity can be well identified with particle size smaller than the diffraction limit, facilitating the morphological identification of single bacteria from a complex matrix in a label-free manner. Furthermore, the manipulation of convection in free solution enables the rapid screening of low-abundance bacteria in a small field of view, which significantly improves the sensitivity of single-particle detection. As a proof of concept demonstration, we are able to differentiate the group B streptococci (GBS)-positive samples within 10 min from vaginal swabs without using any biological reagents. This is the most rapid and low-cost method to the best of our knowledge. We believe that such a single-particle imaging approach will find wider applications in clinical diagnosis and disease control due to its high sensitivity, rapidity, simplicity, and low cost.


Subject(s)
Bacteria , Communicable Diseases , Single-Cell Analysis , Bacteria/isolation & purification , Bacteria/pathogenicity , Communicable Diseases/diagnostic imaging , Female , Humans , Particle Size , Single-Cell Analysis/methods , Vaginal Smears
2.
Ginekol Pol ; 91(6): 301-307, 2020.
Article in English | MEDLINE | ID: mdl-32627150

ABSTRACT

OBJECTIVES: Human papillomavirus (HPV) ranks the first cause of cervical cancer. Cervical cancer has high prevalence rates in women around the world. The HPV-E7 oncoprotein is expressed in cervical cancer and is a target of developing immunotherapies against HPV-associated tumors. However, the antigenicity of this protein is low. Due to this reason, potent adjuvants are required to enhance its therapeutic efficacy. This preliminary study aims to evaluate whether lymphotoxin (LT) could act as an effective immune adjuvant for HPV infection in mice models. MATERIAL AND METHODS: Intranasal immunization was used to explore the effect of HPV-E7 and/or LT immune response. After the third intranasal immunization, the titer for the HPV-E7 antibody was detected in serum and vaginal washing fluid. Also, we assessed the expression of chemokine ligand 13 (CXCL13) and Peripheral Node Addressin (PNAd) in the lymph nodes after intranasal immunization with immunohistochemical analysis. RESULTS: compared to HPV-E7 immunization, intranasal immunization with HPV-E7 plus LT significantly increased HPV-E7-specific serum IgG and vaginal IgA titers. Furthermore, the combined use of HPV-E7 and LT strongly induced E7-specific CTL responses. CONCLUSIONS: LT can be effective for intranasal immunized HPV-E7 to improve E7-specific immune responses to HPV infection. It is new approach to eradicate chronic HPV infection capable of inducing an effective anti-infection method.


Subject(s)
Antigens, Viral/immunology , Lymphotoxin-alpha/immunology , Papillomavirus E7 Proteins/immunology , Papillomavirus Infections/immunology , Viral Vaccines/immunology , Animals , Antibodies, Viral/blood , Disease Models, Animal , Female , Immunity , Immunotherapy , Mice , Papillomavirus Infections/prevention & control , Uterine Cervical Neoplasms/immunology , Uterine Cervical Neoplasms/prevention & control
3.
Cell Cycle ; 16(9): 852-860, 2017 May 03.
Article in English | MEDLINE | ID: mdl-28324667

ABSTRACT

Meiotic failure in oocytes is the major determinant of human zygote-originated reproductive diseases, the successful accomplishment of meiosis largely relay on the normal functions of many female fertility factors. Elmod2 is a member of the Elmod family with the strongest GAP (GTPase-activating protein) activity; although it was identified as a possible maternal protein, its actual physiologic role in mammalian oocytes has not been elucidated. Herein we reported that among Elmod family proteins, Elmod2 is the most abundant in mouse oocytes, and that inhibition of Elmod2 by specific siRNA caused severe meiotic delay and abnormal chromosomal segregation during anaphase. Elmod2 knockdown also significantly decreased the rate of oocyte maturation (to MII, with first polar body extrusion), and significantly greater numbers of Elmod2-knockdown MII oocytes were aneuploid. Correspondingly, Elmod2 knockdown dramatically decreased fertilization rate. To investigate the mechanism(s) involved, we found that Elmod2 knockdown caused significantly more abnormal mitochondrial aggregation and diminished cellular ATP levels; and we also found that Elmod2 co-localized and interacted with Arl2, a GTPase that is known to maintain mitochondrial dynamics and ATP levels in oocytes. In summary, we found that Elmod2 is the GAP essential to meiosis progression of mouse oocytes, most likely by regulating mitochondrial dynamics.


Subject(s)
Cytoskeletal Proteins/metabolism , Meiosis , Oocytes/cytology , Oocytes/metabolism , Adenosine Triphosphate/metabolism , Aneuploidy , Animals , Chromosome Segregation , Female , Fertilization , GTP-Binding Proteins/metabolism , Gene Knockdown Techniques , Mice, Inbred ICR , Mitochondria/metabolism , Ovary/cytology , Ovary/metabolism , Protein Binding
4.
Mol Cell Endocrinol ; 374(1-2): 108-16, 2013 Jul 15.
Article in English | MEDLINE | ID: mdl-23628604

ABSTRACT

SET has multiple cell functions including nucleosome assembly, histone binding, transcription control, and cell apoptosis. In ovaries SET is predominantly expressed in theca cells and oocytes. In our study, SET overexpression in theca cells stimulated testosterone production whereas SET knockdown decreased testosterone production. Moreover, SET negatively regulated PP2A activity. Treatment with PP2A inhibitor okadaic acid (OA) led to increased testosterone synthesis, while treatment with PP2A activators resulted in the decreased testosterone synthesis. Furthermore, PP2A knockdown confirmed the key role of PP2A in the testosterone synthesis, and OA was able to block the AdH1-SiRNA/SET-mediated inhibition of testosterone production. The central role of PP2A in SET-mediated regulation of testosterone production was confirmed by the finding that SET promoted the lyase activity of P450c17 and that PP2A inhibited its lyase activity. Taken together, these results reveal a specific, SET-initiated, PP2A-mediated, pathway that leads to the increased lyase activity of P450c17 and testosterone biosynthesis.


Subject(s)
Oncogene Proteins/genetics , Protein Phosphatase 2/genetics , Testosterone/biosynthesis , Theca Cells/metabolism , Animals , DNA-Binding Proteins , Enzyme Inhibitors/pharmacology , Female , Gene Expression Regulation , Gene Knockdown Techniques , Histone Chaperones , Mice , Mice, Inbred ICR , Okadaic Acid/pharmacology , Oncogene Proteins/metabolism , Primary Cell Culture , Protein Binding , Protein Phosphatase 2/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Signal Transduction , Steroid 17-alpha-Hydroxylase/genetics , Steroid 17-alpha-Hydroxylase/metabolism , Theca Cells/cytology , Theca Cells/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...